Midatech receives confirmation that its Q-Octreotide (MTD201) first in-human EU study is approved
January 09, 2018 07:00 ET
|
Midatech Pharma PLC
9 January 2018Midatech Pharma PLC("Midatech" or the "Company") Midatech receives confirmation that its Q-Octreotide (MTD201) first in-human EU study is approved Midatech (AIM: MTPH,...
Midatech Loan Agreement with MidCap Financial
January 02, 2018 07:00 ET
|
Midatech Pharma PLC
2 January 2018Midatech Pharma PLC("Midatech" or the "Company") Midatech enters into a Loan Agreement with MidCap Financial Midatech (AIM: MTPH, Nasdaq: MTP), the international...
Midatech Pharma US initiates Gelclair® Phase IV trial to study oral mucositis in stem cell transplant patients
December 20, 2017 07:01 ET
|
Midatech Pharma PLC
Midatech Pharma PLC("Midatech" or the "Company") Midatech Pharma US initiates Gelclair® Phase IV trial to study oral mucositis in stem cell transplant patients Trial to be conducted at the...
Midatech Pharma Plc: Midatech submits MTD201 CTA filing for first in human study in carcinoid cancer and acromegaly
September 04, 2017 07:00 ET
|
Midatech Pharma PLC
4 September 2017Midatech Pharma PLC("Midatech", "Company" or "Group") Midatech submits MTD201 CTA filing for first in human study in carcinoid cancer and acromegaly Midatech on track to start...
Midatech Pharma Plc: Completion of pre-clinical liver cancer programme
July 26, 2017 07:00 ET
|
Midatech Pharma PLC
26 July 2017Midatech Pharma PLC("Midatech", "Company" or "Group") Completion of pre-clinical liver cancer programme Midatech Pharma (AIM: MTPH, Nasdaq: MTP), the international specialty...
Midatech Pharma Plc: Trading Update and Notice of Results
July 18, 2017 07:00 ET
|
Midatech Pharma PLC
18 July 2017Midatech Pharma PLC("Midatech", "Company" or "Group") Trading Update and Notice of Results Midatech Pharma (AIM: MTPH, Nasdaq: MTP), the international specialty pharmaceutical...
R&D manufacturing site visit for investors and analysts
June 13, 2017 07:42 ET
|
Midatech Pharma PLC
Midatech Pharma (AIM: MTPH; Nasdaq: MTP), the international specialty pharmaceutical company focused on commercialising and developing products in oncology, is hosting a site visit today at its...
Midatech signs global license agreement to investigate panobinostat for treatment of brain cancers
June 07, 2017 11:15 ET
|
Midatech Pharma PLC
Midatech Pharma (AIM: MTPH; Nasdaq: MTP), the international specialty pharmaceutical company focused on commercialising and developing products in oncology, today announces that it has signed a global...
Midatech Pharma PLC: Midatech Announces Successful Initial Scale-Up of Its Sustained Release Manufacturing Facility
March 10, 2017 07:51 ET
|
Midatech Pharma PLC
Midatech Announces Successful Initial Scale-Up of Its Sustained Release Manufacturing Facility ~ Q-Octreotide will become Midatech's first Sustained Release product candidate manufactured in house at...
Midatech Pharma PLC: Trading Update
January 20, 2017 08:02 ET
|
Midatech Pharma PLC
Midatech Pharma PLC("Midatech", "Company" or "Group") Trading Update Midatech Pharma (AIM: MTPH, Nasdaq: MTP), the international specialty pharmaceutical company focused on developing and...